With a first-of-its-kind GMP facility, AbCellera Biologics is building the future of Canadian biotech, right here in BC
The newly-announced 130,000-square-foot Vancouver facility aims to accelerate the development of antibody-based therapies for an array of medical conditions.
William Johnson
June 22, 2021
Premium Content
Become a paying subscriber of Vancouver Tech Journal Membership to get access to this page and other subscriber-only content.
What you get when you upgrade:
- 🔑 Exclusive content: In-depth stories that you won't find anywhere else
- 🎟️ First access to events we put on
- 🔒 The Morning Report, an email digest of need-to-know stories and deals
- 🗓️ Discounted and invitation-only events
Already a subscriber?Sign In.Upgrade to view premium content.